The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Metrovis 250 mg tablets for dogs and cats

LIVISTO Int'l, S.L.VPA10425/011/002

Main Information

Trade NameMetrovis 250 mg tablets for dogs and cats
Active SubstancesMetronidazole
Dosage FormTablet
Licence HolderLIVISTO Int'l, S.L.
License Holder AddressAv. Universitat Autònoma, 29
08290 Cerdanyola del Vallès
Licence NumberVPA10425/011/002

Group Information

ATC CodeQP51AA01 metronidazole
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued13/08/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back